Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression

被引：3
|
作者：
Souza, Sergio A. [1 ]
Josino, Taina R. [1 ]
Bisol, Luisa W. [1 ]
机构：
[1] Univ Hosp Walter Cantidio, Fortaleza, Brazil
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2023年 / 389卷 / 10期
关键词：
ELECTROCONVULSIVE-THERAPY; REMISSION;
D O I：
10.1056/NEJMc2308757
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
To the Editor: The article by Anand et al. (June 22 issue)(1) concerns an important issue - the therapeutic approach that should be used for patients with treatment-resistant depression. However, the article has some drawbacks. First, bilateral electroconvulsive therapy (ECT) is standard care for treatment-resistant depression. Bilateral ECT has a faster onset and is more efficacious than unilateral ECT.(2) The patients in this trial who ultimately underwent ECT started with unilateral ECT, which may be an indication that the authors were biased toward the ketamine group. It is awkward that after a median of four sessions, 38.8% of the patients . . .
引用
收藏
页码：959 / 962
页数：4
相关论文
共 50 条
  • [1] Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression
    Anand, A.
    Mathew, S. J.
    Sanacora, G.
    Murrough, J. W.
    Goes, F. S.
    Altinay, M.
    Aloysi, A. S.
    Asghar-Ali, A. A.
    Barnett, B. S.
    Chang, L. C.
    Collins, K. A.
    Costi, S.
    Iqbal, S.
    Jha, M. K.
    Krishnan, K.
    Malone, D. A.
    Nikayin, S.
    Nissen, S. E.
    Ostroff, R. B.
    Reti, I. M.
    Wilkinson, S. T.
    Wolski, K.
    Hu, B.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (25): : 2315 - 2325
  • [2] In treatment-resistant major depression, ketamine was noninferior to ECT for treatment response
    Holsinger, Tracey
    Riordan, Paul
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (09) : JC105 - JC105
  • [3] Commentary: Treatment-resistant Depression: Considerations Related to ECT and Ketamine
    Garakani, Amir
    JOURNAL OF PSYCHIATRIC PRACTICE, 2021, 27 (06) : 496 - 497
  • [4] ECT in Treatment-Resistant Depression
    Kellner, Charles H.
    Greenberg, Robert M.
    Murrough, James W.
    Bryson, Ethan O.
    Briggs, Mimi C.
    Pasculli, Rosa M.
    AMERICAN JOURNAL OF PSYCHIATRY, 2012, 169 (12): : 1238 - 1244
  • [5] A comparison of the safety, feasibility, and tolerability of ECT and ketamine for treatment-resistant depression
    Tamman, Amanda
    Anand, Amit
    Mathew, Sanjay J.
    EXPERT OPINION ON DRUG SAFETY, 2022, 21 (06) : 745 - 759
  • [6] Clinical Predictors of Ketamine Response in Treatment-Resistant Major Depression
    Niciu, Mark J.
    Luckenbaugh, David A.
    Ionescu, Dawn F.
    Guevara, Sara
    Machado-Vieira, Rodrigo
    Richards, Erica M.
    Brutsche, Nancy E.
    Zarate, Carlos A.
    BIOLOGICAL PSYCHIATRY, 2014, 75 (09) : 128S - 128S
  • [7] Noninferior to ketamine for treatment-resistant major depression without psychosis
    Lampl, Benedikt M. J.
    ANASTHESIOLOGIE INTENSIVMEDIZIN NOTFALLMEDIZIN SCHMERZTHERAPIE, 2024, 59 (05):
  • [8] Intravenous ketamine therapy in a patient with a treatment-resistant major depression
    Liebrenz, Michael
    Borgeat, Alain
    Leisinger, Ria
    Stohler, Rudolf
    SWISS MEDICAL WEEKLY, 2007, 137 (15-16) : 234 - 236
  • [9] Clinical Predictors of Ketamine Response in Treatment-Resistant Major Depression
    Niciu, Mark J.
    Luckenbaugh, David A.
    Ionescu, Dawn F.
    Guevara, Sara
    Machado-Vieira, Rodrigo
    Richards, Erica M.
    Brutsche, Nancy E.
    Nolan, Neal M.
    Zarate, Carlos A., Jr.
    JOURNAL OF CLINICAL PSYCHIATRY, 2014, 75 (05) : E417 - E423
  • [10] Beneficial Pre-ECT Ketamine Infusion in a Patient with Treatment-Resistant Depression
    Sultan, Ryan
    Riva-Posse, Patricio
    Garlow, Steven J.
    Schwartz, Ann C.
    PSYCHOSOMATICS, 2014, 55 (04) : 396 - 399
12345